Live vom ASCO 2010:
Prof. Jens-Uwe Blohmer diskutiert mit weiteren Experten neue Studiendaten und aktuelle Entwicklungen bei der Therapie des Mammakarzinoms. Sie finden die Expertenrunde Mammakarzinom auf dem Internetportal der Deutschen Krebsgesellschaft e.V.* [mehr…]
Live vom ASCO 2009:
Sehen Sie Prof. Dr. Jens-Uwe Blohmer in der Video-Expertenrunde zum Thema gynäkologische Tumoren auf dem Internetportal der Deutschen Krebsgesellschaft e.V.* [mehr…]
Live vom SABCS 2008:
Sehen Sie Prof. Dr. med. Jens-Uwe Blohmer in der Video-Expertenrunde zum Thema Mammakarzinom auf dem Internetportal der Deutschen Krebsgesellschaft e.V.* [mehr…]
*) Beachten Sie, dass diese Information für Mediziner bestimmt ist und deshalb ein Login (z.B. Doc-Check) erfordert.
Eine aktuelle Liste der wissenschaftlichen Publikationen von Prof. Dr. med. Blohmer finden Sie auf der Webseite von PubMed
1. Kummel S, Heidecke H, Brock B, Denkert C, Hecktor J, Koninger A, Becker I, Sehouli J, Thomas A, Blohmer JU, Lichtenegger W, Kimmig R.
Imatinib--a possible therapeutic option for cervical carcinoma: results of a preclinical phase I study.
Gynakol Geburtshilfliche Rundsch. 2008 48(2):94-100. Epub 2008 Apr 16. German.
2. Blohmer JU, Kimmig R, Kummel S, Costa SD, Kramer S, Rezai M.
Intraoperative radiotherapy of breast cancer.
Gynakol Geburtshilfliche Rundsch. 2008 48(2):63-7. Epub 2008 Apr 16. Review. German.
3. von Minckwitz G, Sinn HP, Raab G, Loibl S, Blohmer JU, Eidtmann H, Hilfrich J, Merkle E, Jackisch C, Costa SD, Caputo A, Kaufmann M; German Breast Group.
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.
Breast Cancer Res. 2008 10(2):R30. Epub 2008 Apr 1.
4. Kümmel S, Eggemann H, Lüftner D, Gebauer N, Bühler H, Schaller G, Schmid P, Kreienberg R, Emons G, Kriner M, Elling D, Blohmer JU, Thomas A.
Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes.
Int J Biol Markers. 2007 Jul-Sep;22(3):186-93.
5. Loibl S, von Minckwitz G, Raab G, Blohmer JU, Dan Costa S, Gerber B, Eidtmann H, Petrich S, Hilfrich J, Jackisch C, du Bois A, Kaufmann M.
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
Ann Surg Oncol. 2006 Nov;13(11):1434-42. Epub 2006 Sep 17.
6. Thomas A, Fischer T, Frey H, Ohlinger R, Grunwald S, Blohmer JU, Winzer KJ, Weber S, Kristiansen G, Ebert B, Kümmel S.
Real-time elastography--an advanced method of ultrasound: First results in 108 patients with breast lesions.
Ultrasound Obstet Gynecol. 2006 Sep;28(3):335-40.
7. Pfisterer J, Weber B, Reuss A, Kimmig R, du Bois A, Wagner U, Bourgeois H, Meier W, Costa S, Blohmer JU, Lortholary A, Olbricht S, Stähle A, Jackisch C, Hardy-Bessard AC, Möbus V, Quaas J, Richter B, Schröder W, Geay JF, Lück HJ, Kuhn W, Meden H, Nitz U, Pujade-Lauraine E; AGO-OVAR; GINECO.
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
J Natl Cancer Inst. 2006 Aug 2;98(15):1036-45.
8. Paepke S, Jacobs VR, Paepke D, Euler U, Blohmer JU, Warm M, Ohlinger R, Fischer T, Kiechle M, Harbeck N.
Critical appraisal of primary systemic endocrine therapy in receptor-positive postmenopausal breast cancer: an update.
Onkologie. 2006 May;29(5):210-7. Epub 2006 May 3. Review.
9. Kümmel S, Krocker J, Kohls A, Breitbach GP, Morack G, Budner M, Blohmer JU, Elling D.
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
Br J Cancer. 2006 May 8;94(9):1237-44.
10. Kaufmann M, Hortobagyi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, Blohmer JU, Eiermann W, Jackesz R, Jonat W, Lebeau A, Loibl S, Miller W, Seeber S, Semiglazov V, Smith R, Souchon R, Stearns V, Untch M, von Minckwitz G.
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
J Clin Oncol. 2006 Apr 20;24(12):1940-9. Erratum in: J Clin Oncol. 2006 Jul 1;24(19):3221.
11. Kümmel S, Eggemann H, Lüftner D, Thomas A, Jeschke S, Zerfel N, Heilmann V, Emons G, Zeiser T, Ulm K, Kobl M, Korlach S, Schmid P, Sehouli J, Elling D, Blohmer JU.
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
Anticancer Res. 2006 Mar-Apr;26(2C):1719-26.
12. Kümmel S, Thomas A, Jeschke S, Hauschild M, Sehouli J, Lichtenegger W, Blohmer JU.
Postoperative therapy modalities for cervical carcinoma.
Anticancer Res. 2006 Mar-Apr;26(2C):1707-13. Review.
13. Blohmer JU, Reinhardt M, Schmalisch G, Lichtenegger W, Hausschild M, Kümmel S, Fischer T, Ohlinger R, Thomas A.
Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent.
Anticancer Res. 2006 Mar-Apr;26(2C):1691-8.
14. Thomas A, Ohlinger R, Hauschild M, Mustea A, Blohmer JU, Kümmel S.
Options and limits of surgery after pre-operative chemotherapy in breast cancer.
Anticancer Res. 2006 Mar-Apr;26(2C):1677-82. Review.
15. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD.
Black cohosh and St. John's wort for climacteric complaints: a randomized trial.
Obstet Gynecol. 2006 Feb;107(2 Pt 1):247-55.
16. Kümmel S, Krocker J, Kohls A, Breitbach GP, Morack G, Budner M, Blohmer JU, Lichtenegger W, Elling D.
Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Crit Rev Oncol Hematol. 2006 May;58(2):166-75. Epub 2006 Jan 18.
17. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Klingebiel T, Louwen F, Kaufmann M.
Breast carcinoma during pregnancy. International recommendations from an expert meeting.
Cancer. 2006 Jan 15;106(2):237-46.
18. Otter H, Martin J, Bäsell K, von Heymann C, Hein OV, Böllert P, Jänsch P, Behnisch I, Wernecke KD, Konertz W, Loening S, Blohmer JU, Spies C.
Validity and reliability of the DDS for severity of delirium in the ICU.
Neurocrit Care. 2005;2(2):150-8.
19. Kümmel S, Thomas A, Paepke S, Schwarz M, Heinrich G, Wetzel A, Elling D, Kohls A, Lichtenegger W, Blohmer JU.
Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
Acta Oncol. 2005;44(3):248-54.
20. Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, Ashley SE, Francis S, Boeddinghaus I, Walsh G; IMPACT Trialists Group.
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
J Clin Oncol. 2005 Aug 1;23(22):5108-16. Epub 2005 Jul 5.
21. Blohmer JU, Dunst J, Harrison L, Johnston P, Khayat D, Ludwig H, O'Brien M, Van Belle S, Vaupel P.
Cancer-related anemia: biological findings, clinical implications and impact on quality of life.
Oncology. 2005;68 Suppl 1:12-21. Review.
22. von Minckwitz G, Raab G, Caputo A, Schütte M, Hilfrich J, Blohmer JU, Gerber B, Costa SD, Merkle E, Eidtmann H, Lampe D, Jackisch C, du Bois A, Kaufmann M.
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.
J Clin Oncol. 2005 Apr 20;23(12):2676-85.
23. Schmid P, Krocker J, Schulz CO, Michniewicz K, Dieing A, Eggemann H, Heilmann V, Blohmer JU, Sezer O, Elling D, Possinger K.
Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial.
Anticancer Drugs. 2005 Jan;16(1):21-9.
24. von Minckwitz G, Blohmer JU, Raab G, Löhr A, Gerber B, Heinrich G, Eidtmann H, Kaufmann M, Hilfrich J, Jackisch C, Zuna I, Costa SD; German Breast Group.
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.
Ann Oncol. 2005 Jan;16(1):56-63.
25. Schmid P, Krocker J, Morack G, Heilmann V, Blohmer JU, Michniewicz K, Köhler G, Schaller-Kranz T, Possinger K, Elling D.
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study.
J Cancer Res Clin Oncol. 2004 Nov;130(11):657-63. Epub 2004 Aug 20.
26. Hildebrandt B, Rau B, Gellermann J, Kerner T, Nicolaou A, Blohmer JU, Trappe RU, Riess H, Wust P.
[Standards and perspectives in locoregional hyperthermia]
Wien Med Wochenschr. 2004 Apr;154(7-8):148-58. Review. German.
27. Untch M, Eidtmann H, du Bois A, Meerpohl HG, Thomssen Ch, Ebert A, Harbeck N, Jackisch C, Heilman V, Emons G, Wallwiener D, Wiese W, Blohmer JU, Höffken K, Kuhn W, Reichardt P, Muscholl M, Pauschinger M, Langer B, Lück HJ.
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial.
Eur J Cancer. 2004 May;40(7):988-97.
28. Diekmann F, Diekmann S, Beljavskaja M, Bick U, Taupitz M, Blohmer JU, Winzer KJ, Hamm B.
[Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma]
Rofo. 2004 Apr;176(4):544-9. German.
29. Pfisterer J, du Bois A, Wagner U, Quaas J, Blohmer JU, Wallwiener D, Hilpert F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Gynecol Oncol. 2004 Mar;92(3):949-56.
30. Maza S, Thomas A, Winzer KJ, Hüttner C, Blohmer JU, Hauschild M, Richter M, Krössin T, Geworski L, Zander A, Guski H, Munz DL.
Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Eur J Nucl Med Mol Imaging. 2004 May;31(5):671-5. Epub 2004 Jan 27.
31. Paepke S, V Minckwitz G, Kaufmann M, Schwarz-Boeger U, Jacobs VR, Aigner M, Pfeifer K, Ehmer M, Hüttner C, Blohmer JU, Kiechle M.
[Chemoprevention of breast cancer: a literature review and report on the current status in Germany]
Zentralbl Gynakol. 2003 Sep;125(9):338-45. Review. German.
32. Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, Blohmer JU, Sinn HP, Sittek R, Souchon R, Tulusan AH, Volm T, Senn HJ.
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.J Clin Oncol. 2003 Jul 1;21(13):2600-8. Review. Erratum in: J Clin Oncol. 2003 Dec 1;21(23):4469.
33. Rein DT, Kurbacher CM, Breidenbach M, Schöndorf T, Schmidt T, König E, Göhring UJ, Blohmer JU, Mallmann P.
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study.
Gynecol Oncol. 2002 Oct;87(1):98-103.
34. Jackisch C, von Minckwitz G, Eidtmann H, Costa SD, Raab G, Blohmer JU, Schütte M, Gerber B, Merkle E, Gademann G, Lampe D, Hilfrich J, Tulusan AH, Caputo A, Kaufmann M.
Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.
Clin Breast Cancer. 2002 Oct;3(4):276-80.
35. Schedel H, Oellinger H, Kohlschein P, Siewert C, Hadijuana J, Blohmer JU, Kissner T, Felix R.
Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
Zentralbl Gynakol. 2002 Feb;124(2):104-10.
36. Diekmann F, Diekmann S, Bick U, Rogalla P, Blohmer JU, Winzer KJ, Hamm B.
[Comparing the visualization of microcalcifications with direct magnification in digital full-field mammography vs. film-screen mammography]
Rofo. 2002 Mar;174(3):297-300. German.
37. von Minckwitz G, Raab G, Schütte M, Hilfrich J, Blohmer JU, Gerber B, Costa SD, Merkle E, Eidtmann H, Lampe D, Jackisch C, du Bois A, Tulusan AH, Gademann G, Sinn HP, Caputo A, Graf E, Kaufmann M.
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]
Zentralbl Gynakol. 2001 Sep;123(9):497-504. Review. German.
38. du Bois A, Lück HJ, Pfisterer J, Schroeder W, Blohmer JU, Kimmig R, Moebus V, Quaas J.
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.
Ann Oncol. 2001 Aug;12(8):1115-20.
39. von Minckwitz G, Costa SD, Raab G, Blohmer JU, Eidtmann H, Hilfrich J, Merkle E, Jackisch C, Gademann G, Tulusan AH, Eiermann W, Graf E, Kaufmann M; German Preoperative Adriamycin-Docetaxel and German Adjuvant Breast Cancer Study Groups.
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study.
J Clin Oncol. 2001 Aug 1;19(15):3506-15.
40. Blohmer JU, Paepke S, Böhmer D, Ernhardt B, Sehouli J, Elling D, Lichtenegger W.
[Adjuvant chemotherapy of cervix carcinoma--results of a phase II study]
Zentralbl Gynakol. 2001 May;123(5):286-91. German.
41. Sezer O, Langelotz C, Blohmer JU, Schmid P, Akrivakis K, Possinger K.
Detection of HMGI-C in the peripheral blood of breast cancer patients.
Eur J Cancer. 2000 Oct;36(15):1944-8.
42. Oellinger JJ, Blohmer JU, Michniewicz K, Siewert C, Wust P, Gutberlet M, Lichtenegger W, Felix R.
Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results.
Zentralbl Gynakol. 2000;122(2):82-91.
43. Blohmer JU, Paepke S, Kissner L, Elling D, Fleige B, Grineisen Y, Lichtenegger W.
Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission.
Zentralbl Gynakol. 1999;121(11):522-5.
44. von Minckwitz G, Costa SD, Eiermann W, Blohmer JU, Tulusan AH, Jackisch C, Kaufmann M.
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel.
J Clin Oncol. 1999 Jul;17(7):1999-2005.
45. Sezer O, Jugovic D, Blohmer JU, Turzynski A, Thiel G, Langelotz C, Possinger K, Kovar H.
CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasms.
Diagn Mol Pathol. 1999 Sep;8(3):120-4.
46. Costa SD, von Minckwitz G, Raab G, Blohmer JU, Dresel V, Eidtmann H, Hilfrich J, Jackisch C, Merkle E, Gademann G, Kaufmann M.
The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
Semin Oncol. 1999 Jun;26(3 Suppl 9):24-31. Review.
47. Blohmer JU, Oellinger H, Schmidt C, Hufnagl P, Felix R, Lichtenegger W.
Comparison of various imaging methods with particular evaluation of color Doppler sonography for planning surgery for breast tumors.
Arch Gynecol Obstet. 1999;262(3-4):159-71.
48. Blohmer JU, Schmalisch G, Klette I, Grineisen Y, Kohls A, Guski H, Lichtenegger W.
Increased incidence of cervical intraepithelial neoplasia in young women in the Mitte district, Berlin, Germany.
Acta Cytol. 1999 Mar-Apr;43(2):195-200.
49. Oellinger H, Blohmer JU, Siewert C, Hadijuana J, Gutberlet M, Ehrenstein T, Lichtenegger W, Felix R.
[Optimal use of MRI mammography from the economic viewpoint]
Zentralbl Chir. 1998;123 Suppl 5:42-6. German.
50. Oellinger JJ, Michniewicz K, Blohmer JU, Hosten N, Siewert C, Lichtenegger W, Felix R.
[Cervix carcinoma: staging, therapy, after-care. Experiences with magnetic resonance tomography of cervix carcinoma based on recent literature 1993 to 1997]
Zentralbl Gynakol. 1998;120(8):373-85. Review. German.
51. Richter K, Heywang-Köbrunner SH, Winzer KJ, Schmitt KJ, Prihoda H, Frohberg HD, Guski H, Gregor P, Blohmer JU, Fobbe F, Döinghaus K, Löhr G, Hamm B.
Detection of malignant and benign breast lesions with an automated US system: results in 120 cases.
Radiology. 1997 Dec;205(3):823-30.
52. Sherif H, Mahfouz AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz M, Felix R, Hamm B.
Peripheral washout sign on contrast-enhanced MR images of the breast.
Radiology. 1997 Oct;205(1):209-13.
53. Siewert C, Oellinger H, Sherif HK, Blohmer JU, Hadijuana J, Felix R.
Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
MAGMA. 1997 Mar;5(1):29-31.
54. Blohmer JU, Bollmann R, Heinrich G, Paepke S, Lichtenegger W.
[Three-dimensional ultrasound study (3-D sonography) of the female breast]
Geburtshilfe Frauenheilkd. 1996 Apr;56(4):161-5. German.
55. Bloechle M, Sydow P, Blohmer JU, Schreiner T, Lisse K.
[Vaginal reconstruction in vaginal aplasia by a Vecchietti modified laparoscopic operation--further simplification of the method]
Zentralbl Gynakol. 1996;118(5):303-6. German.
56. Blohmer JU, Chaoui R, Schmalisch G, Bollmann R, Lau HU.
[Differential breast tumor diagnosis by comparing blood circulation of the tumor with the contralateral breast using color coded, pulsed Doppler ultrasound]
Geburtshilfe Frauenheilkd. 1995 Jan;55(1):1-6. German.
57. Blohmer JU, Bollmann R, Chaoui R, Kürten A, Lau HU.
[Non-puerperal mastitis in real time and color Doppler ultrasound]
Geburtshilfe Frauenheilkd. 1994 Mar;54(3):161-6. German.
58. Blohmer JU, Janda J, Guski H, Lau HU.
[Fibromatosis of the breast--a case report and review of the literature]
Zentralbl Gynakol. 1994;116(1):52-5. Review. German.
59. Blohmer JU, Lau HU.
[The beginning of gynecologic cytology for cancer diagnosis in Germany]
Zentralbl Gynakol. 1994;116(6):365-7. German.
60. Blohmer JU, Caemmerer CD, Bollmann R, Bartho S.
[References for prenatal diagnosis of morphological defects including the central nervous system]
Ultraschall Med. 1993 Feb;14(1):8-12. German.
61. Blohmer JU, Kohls A, Lau HU.
[Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy]
Zentralbl Gynakol. 1993;115(2):86-9. German.
Mitarbeit an 4 Lehrbüchern, 46 Publikationen zum Mammakarzinom, mehr als 100 Publikationen insgesamt.
Eine aktuelle Liste der wissenschaftlichen Publikationen finden Sie auf der Webseite von PubMed